General population screening for type 1 diabetes: Has its time come?

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 22, Issue 4, 2015, Pages 270-276

  Insel, Richard A ^a   Dunne, Jessica L ^a   Ziegler, Anette G ^b,c  

^a JDRF   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

disease staging; prevention; risk screening; type 1 diabetes

Indexed keywords

AUTOANTIBODY;

ANTIBODY DETECTION; ASYMPTOMATIC DISEASE; CHILD; CHILD CARE; COST BENEFIT ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DYSGLYCEMIA; FAMILY HISTORY; FOLLOW UP; GENOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MASS SCREENING; PEDIATRICS; PREVENTIVE HEALTH SERVICE; REVIEW; RISK ASSESSMENT; STANDARD; DIABETES MELLITUS, TYPE 1; EARLY DIAGNOSIS; RISK; STANDARDS;

CHILD; DIABETES MELLITUS, TYPE 1; EARLY DIAGNOSIS; HUMANS; MASS SCREENING; RISK;

EID: 84937774881     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000173     Document Type: Review

References (21)

1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014; 383: 69-82
2. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med. 2009; 360: 1646-1654
3. Patterson CC, Dahlquist GG, Gyürüs E, et al., EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009; 373: 2027-2033
4. Harjutsalo V, Sjö berg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet. 2008; 371: 1777-1782
5. Defining the Early Stages of Type 1 Diabetes, http://cdn.jdrf.org/wp-content/.uploads/2012/12/Defining-The-Early-Stages-of-T1D-Workshop-Presentations-10-10-2014.pdf. [Accessed 3 May 2015
6. Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial - Type 1. Diabetes Care. 2005; 28: 1068-1076
7. Mahon JL, Sosenko JM, Rafkin-Mervis L, et al. TrialNet Natural History Committee; Type 1 Diabetes TrialNet Study Group. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes. 2009; 10: 97-104
8. Hagopian WA, Erlich H, Lernmark A, et al., TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes. 2011; 12: 733-743
9. Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013; 309: 2473-2479
10. Strebelow M, Schlosser M, Ziegler B, et al. Karlsburg Type I diabetes risk study of a general population: frequencies and interactions of the four major Type I diabetes-Associated autoantibodies studied in 9419 schoolchildren. Diabetologia. 1999; 42: 661-670
11. Bingley PJ, Bonifacio E, Williams AJ, et al. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 1997; 46: 1701-1710
12. LaGasse JM, Brantley MS, Leech NJ, et al. Washingtno State Diabetes Prediction Study. Successful prospective prediction of T1D in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care. 2002; 25: 505-511
13. Ziegler AG, Bonifacio E. BABYDIAB-BABYDIET Study Group. Age-related islet autoantibody incidence in offspring of patients with T1D. Diabetologia. 2012; 55: 1937-1943
14. Parikka V, Näntö -Salonen K, Saarinen M, et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of T1D in children at genetic risk. Diabetologia. 2012; 55: 1926-1936
15. Krischer JP, Lynch KF, Schatz D A, et al., The TEDDY Study Group. The sixyear incidence of diabetes associated autoantibodies in genetically at-risk children: the TEDDY Study. Diabetologia. 2015; 58: 980-987
16. Chmiel R, Giannopoulou EZ, Winkler C, et al. Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: implications for early screening. Diabetologia. 2015; 58: 411-413
17. Elding Larsson H1, Vehik K, Bell R, et al., TEDDY Study Group; SEARCH Study Group; Swediabkids Study Group; DPV Study Group; Finnish Diabetes Registry Study Group. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care. 2011; 34: 2347-2352
18. Barker JM, Goehrig SH, Barriga K, et al., DAISY Study. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up diabetes. Care. 2004; 27: 1399-1404
19. Roth R, Lynch K, Lernmark B, et al., The TEDDY Study Group. Maternal anxiety about a childs diabetes risk in the TEDDY study: the potential role of life stress, postpartum depression, and risk perception. Pediatr Diabetes. 2015; 16: 287-298
20. Dabelea D, Rewers A, Stafford JM, et al., SEARCH for Diabetes in Youth Study Group. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014; 133: e938-e945
21. Helminen O, Aspholm S, Pokka T, et al. HbA1c predicts time to diagnosis of type 1 diabetes in children at risk. Diabetes. 2014; 64: 1719-1727